Harvard Bioscience, Inc.
HBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,405 | -$3,415 | -$9,516 | -$288 |
| Dep. & Amort. | $7,157 | $6,998 | $7,575 | $7,621 |
| Deferred Tax | $363 | $336 | -$414 | -$330 |
| Stock-Based Comp. | $4,340 | $5,000 | $4,411 | $4,169 |
| Change in WC | $65 | $4,600 | $2,716 | -$10,190 |
| Other Non-Cash | $1,920 | $509 | -$3,620 | $280 |
| Operating Cash Flow | $1,440 | $14,028 | $1,152 | $1,262 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,644 | -$1,788 | -$1,590 | -$1,195 |
| Net Acquisitions | $0 | $512 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $1,919 | $0 | $0 | $0 |
| Other Inv. Act. | -$619 | -$523 | $0 | -$150 |
| Investing Cash Flow | -$1,344 | -$1,799 | -$1,590 | -$1,345 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $227 | -$10,541 | -$1,786 | $50 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$1,628 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$358 | -$1,593 | $577 | -$302 |
| Financing Cash Flow | -$131 | -$12,134 | -$2,837 | -$252 |
| Forex Effect | -$140 | -$320 | -$38 | -$161 |
| Net Chg. in Cash | -$175 | -$225 | -$3,313 | -$496 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,283 | $4,508 | $7,821 | $8,317 |
| End Cash | $4,108 | $4,283 | $4,508 | $7,821 |
| Free Cash Flow | -$1,823 | $11,717 | -$438 | -$83 |